| Business Summary | | Avatex
Corporation
is
a
holding
company
that,
along
with
its
subsidiaries,
owns
interests
in
other
corporations
and
partnerships.
Through
Phar-Mor,
Inc.,
the
Company's
47%-owned
affiliate,
the
Company
is
involved
in
operating
a
chain
of
discount
retail
drugstores.
Through
Phar-Mor
and
the
Company's
41%-owned
affiliate,
Chemlink
Acquisition
Company,
LLC
(CLAC),
the
Company
owns
approximately
38%
and
controls
50%,
of
the
membership
interests
of
Chemlink
Laboratories,
LLC
(Chemlink).
Chemlink
is
primarily
engaged
in
the
development,
manufacture
and
distribution
of
effervescent
tablet
and
granule
formulations
for
consumers
and
businesses
for
use
in
cleaning,
disinfecting
and
sterilization
applications. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Avatex
Corporation,
along
with
its
subsidiaries,
operates
a
drugstore
chain
and
owns
interest
in
a
development
stage
company.
For
the
three
months
ended
6/30/01,
the
Company
reported
no
revenues.
Net
loss
before
extraordinary
items
fell
39%
to
$4.2
million.
Results
reflect
an
increase
in
other
income
due
primarily
to
a
gain
on
the
sale
of
the
Company's
investment
in
HPD
and
the
recovery
of
a
prior
asset
written
off. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Abbey Butler, 63 Co-Chairman
and Co-CEO | $983K | Melvyn Estrin, 57 Co-Chairman
and Co-CEO | 968K | Grady Schleier, 48 Sr.
VP, CFO, Treasurer | 235K | John Murray, 44 VP-Fin. | 224K | Robert Stone, 40 VP,
Sec. and Gen. Counsel | 224K | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|